Home > Research > Browse

Results for Neuroprotection

Publications & Outputs

  1. Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus

    Wang, R-F., Xue, G-F., Hölscher, C., Tian, M-J., Feng, P., Zheng, J-Y. & Li, D-F., 05/2018, In : Epilepsy Research. 142, p. 45-52 8 p.

    Research output: Contribution to journalJournal article

  2. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease

    Jalewa, J., Sharma, M. K., Gengler, S. & Hölscher, C., 1/05/2017, In : Neuropharmacology. 117, p. 238-248 11 p.

    Research output: Contribution to journalJournal article

  3. Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model

    Li, Y., Liu, W., Li, L. & Holscher, C., 02/2016, In : Neuropharmacology. 101, p. 255-263 9 p.

    Research output: Contribution to journalJournal article

  4. Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson's disease mouse model

    Zhang, Y., Chen, Y., Li, L. & Holscher, C., 15/10/2015, In : Behavioural Brain Research. 293, p. 107-113 7 p.

    Research output: Contribution to journalJournal article

  5. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer ‘s disease

    McClean, P. L. & Holscher, C., 2013, In : Neuropharmacology. 76, Part A, p. 57-67 11 p.

    Research output: Contribution to journalJournal article

  6. Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

    Hunter, K. & Holscher, C., 2012, In : BMC Neuroscience. 13, p. 33-38 6 p.

    Research output: Contribution to journalJournal article